Trial Profile
A Study to Evaluate the Efficacy of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) with A History of Child Abuse
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2016
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 17 Feb 2016 New trial record